Mohamed Ahmed Hassan

Lecturer

 (email)

Publications

Export 1 results:
  • Tagged
  • XML
  • BibTex
Sort by: [ Author  (Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q [R] S T U V W X Y Z   [Show ALL]
H
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole., Hassan Metwally, Mohamed A., Ali Rubina, Kuddu Maire, Shouman Tarek, Strojan Primoz, Overgaard Jens, and Grau Cai , Acta oncologica (Stockholm, Sweden), 2015, Volume 54, Issue 9, p.1673-7, (2015)
  • Publications
  • Bio
  • Classes
  • Calendar

Recent Publications

Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials.
Study of the population pharmacokinetic characteristics of nimorazole in head and neck cancer patients treated in the DAHANCA-5 trial.
IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma.
Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).
more

Login Powered by OpenScholar